UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 427.4 EUR Market Closed

Market Cap: €12B

U	United Therapeutics Corp XBER:UTH	US
A	Andritz AG XMUN:AZ2	AT
P	Paladin Energy Ltd XMUN:PUR	AU
	Pluxee NV OTC:PLXNF	FR
B	Bgc Group Inc NASDAQ:BGC	US
S	Suzuki Motor Corp DUS:SUK	JP
	Tata Technologies Ltd NSE:TATATECH	IN
N	National Grid PLC F:NNGD	UK
F	Fortune Brands Home & Security Inc F:2FB	US
L	Leonardo SpA DUS:FMNB	IT
P	PTC Inc F:PMTA	US
	Pfizer Ltd NSE:PFIZER	IN
	Savills PLC LSE:SVS	UK

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Declining Net Margin

41% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

32% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.